Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report
Laurenz Nagl, Lena Horvath, Arno Amann, Lorenz Schreiner, Michael Günther, Herbert Maier, Johannes Kerschbaumer, Gerlig Widmann, Danijela Minasch, Lisa-Maria Rossetti, Katharina Kostenzer, Dominik Wolf, Florian Augustin, Andreas Pircher · 2026
Read Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report by Laurenz Nagl, Lena Horvath, Arno Amann, Lorenz Schreiner, Michael Günther, Herbert Maier, Johannes Kerschbaumer, Gerlig Widmann, Danijela Minasch, Lisa-Maria Rossetti, Katharina Kostenzer, Dominik Wolf, Florian Augustin, Andreas Pircher (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13321012.txt.
Description
Laurenz Nagl and a large Austrian team describe, in 2026, complete disappearance of a lung cancer after targeted antibody-drug treatment in a patient with limited spread. The cancer carried a rare HER2 gene insertion. The linked drug, trastuzumab deruxtecan, is proven in previously treated patients, but its use as first treatment in oligometastatic disease was undocumented.
The 66-year-old woman had a lung mass and one symptomatic brain metastasis, which was removed and irradiated. She declined standard chemotherapy and immunotherapy. An individualised plan used the targeted drug alone first. After four cycles, imaging showed major shrinkage. Surgery on the lung tumour then found no living cancer at all in the removed tissue. Drug treatment continued afterward. The authors call for prospective trials of this approach.
Catalog record
| CREATOR | Laurenz Nagl, Lena Horvath, Arno Amann, Lorenz Schreiner, Michael Günther, Herbert Maier, Johannes Kerschbaumer, Gerlig Widmann, Danijela Minasch, Lisa-Maria Rossetti, Katharina Kostenzer, Dominik Wolf, Florian Augustin, Andreas Pircher |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |